What is Qubit Pharmaceuticals?
Qubit Pharmaceuticals is an innovative drug discovery company leveraging advanced simulation software and AI-enhanced medicinal chemistry. The firm specializes in developing novel drug candidates and creating innovative modes of action against challenging therapeutic targets. By designing drug candidates atom by atom, Qubit Pharmaceuticals aims to optimize efficiency and specificity while ensuring a favorable safety profile, achieving this at unprecedented speed.
How much funding has Qubit Pharmaceuticals raised?
Qubit Pharmaceuticals has raised a total of $16.9M across 1 funding round:
Angel/Seed
$16.9M
Angel/Seed (2022): $16.9M with participation from Quantonation, Omnes Capital, and XAnge
Key Investors in Qubit Pharmaceuticals
Quantonation
Quantonation is an early-stage venture capital fund globally investing in novel technologies based on advances in physics and/or computing, supporting the commercialization of quantum technologies.
Omnes Capital
Omnes Capital is a leading European private equity firm focused on the energy transition and deeptech innovation, managing over 6.7 billion euros in assets.
XAnge
XAnge is a European early-stage venture capital firm with €700M AUM, dedicated to empowering visionary founders from Seed to Series B with capital and expertise.
What's next for Qubit Pharmaceuticals?
The recent major strategic investment suggests Qubit Pharmaceuticals is poised for significant scaling and further development of its proprietary drug discovery platform. This capital infusion will likely accelerate the advancement of its pipeline, enabling the company to tackle more complex diseases and potentially bring novel therapeutics to market. The focus on physics and AI indicates a commitment to cutting-edge research and development, positioning the company for continued growth and innovation in the pharmaceutical industry.
See full Qubit Pharmaceuticals company page
